N/A N=43 Transcutaneous Electrical Nerve Stimulation (TENS) and Fibromyalgia (FM)
Fibromyalgia
Primary: Pain at Rest Difference Score Pre-intervention and Post Intervention — 0.38; -0.74; -0.47 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=301 Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST)
Fibromyalgia
Primary: Pain Rating With Movement (0-10 Low to High Scale) During Six Minute Walk Test — -1.8; -0.8; 0.00; -2.0 Units on a scale — p=0.008
Phase 2 N=56 Neurotropin Treatment of Fibromyalgia
Fibromyalgia
Primary: Fibromyalgia Impact Questionnaire — 49.9; 37.5; 39.9; 33.4 units on a scale
Phase 3 N=114 Coping Skills Training for Adolescents With Fibromyalgia
Fibromyalgia
Primary: Change in FDI (Functional Disability Inventory) Scores at End of Study — 21.4; 19.2; 13.4; 17.0 units on a 0-60 scale — p=0.007
Phase 4 N=22 A Study to Evaluate the Effects of Milnacipran on Pain Processing and Functional MRI in Patients With Fibromyalgia
Fibromyalgia
Primary: Pain Threshold at Baseline — 2.7333; 2.583 kg/cm^2
Phase 4 N=19 The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
Sleep Disorders · Fibromyalgia · Sleep
Primary: Number of Awakenings After Sleep Onset (NAASO) — 39.5; 34.9 Awakenings — p=0.424
N/A N=80 Effectiveness of Dance on Patients With Fibromyalgia
Fibromyalgia
Primary: Visual Analog Scale for Pain — 75; 75; 75; 46 mm — p=<0.001
N/A N=48 Randomized Controlled Trial of CES for Fibromyalgia
Fibromyalgia
Primary: Clinical Pain Change — -0.97; -1.75; -1.38; -2.00 Change (from baseline) in DVPRS score
N/A N=317 Fibromyalgia Integrative Training for Adolescents With Juvenile Fibromyalgia
Fibromyalgia · Myofascial Pain Syndrome · Muscular Diseases
Primary: Functional Disability Inventory — 25.78; 24.10; 25.96; 21.83 score on a scale
N/A N=21 Feasibility Study: fMRI Evaluation of Auricular PENFS for Fibromyalgia
Fibromyalgia
Primary: fcMRI as a Biomarker to Investigate Functionally Correlated Neural Substrates of Pain in Patients Undergoing PENFS — 0; 0; 0; 0 Cluster size (voxels) — p=<0.05
N/A N=1,700 Fibromyalgia Health Outcome Study on Cost of Treatments
Fibromyalgia
Primary: Cumulative Number of Medications Taken for Fibromyalgia (FM) Over 12 Months — 5.2 medications
Phase 2 N=67 "SMART-FM": Smart-Phone Based Digital Therapeutic for Management of Fibromyalgia
Fibromyalgia
Primary: Revised Fibromyalgia Impact Questionnaire (FIQ-R) Total Score — -8.7; -3.0 score on a scale
Phase 2 N=22 Evaluate the Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia
Fibromyalgia
Primary: Mean (SD) Glx/Total Creatine Levels in Dorsal Anterior Cingulate Cortex (dACC): NYX-2925 20 mg and 200 mg PO QD at Week 4 and Week 6, Respectively. — 2.1670; 2.0550…
N/A N=51 Study of T3 for the Treatment of Fibromyalgia
Fibromyalgia
Primary: Visual Analogue Scale of Pain Intensity — 6.75; 5.71; 5.13; 6.19 Units on a scale
Phase 3 N=193 A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Fibromyalgia
Primary: Mean NRS Pain Score at End of Period. — 4.84; 5.45 Units on a scale — p=0.0001